Sökning: WFRF:(Sfarti C.) > (2022) > Functional bowel di...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04675naa a2200889 4500 | |
001 | oai:gup.ub.gu.se/320178 | |
003 | SwePub | |
008 | 240528s2022 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/3201782 URI |
024 | 7 | a https://doi.org/10.1002/ueg2.122592 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Savarino, E.4 aut |
245 | 1 0 | a Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility |
264 | c 2022-06-13 | |
264 | 1 | b Wiley,c 2022 |
520 | a Irritable bowel syndrome with diarrhoea (IBS-D) and functional diarrhoea (FDr) are the two major functional bowel disorders characterized by diarrhoea. In spite of their high prevalence, IBS-D and FDr are associated with major uncertainties, especially regarding their optimal diagnostic work-up and management. A Delphi consensus was performed with experts from 10 European countries who conducted a literature summary and voting process on 31 statements. Quality of evidence was evaluated using the grading of recommendations, assessment, development, and evaluation criteria. Consensus (defined as >80% agreement) was reached for all the statements. The panel agreed with the potential overlapping of IBS-D and FDr. In terms of diagnosis, the consensus supports a symptom-based approach also with the exclusion of alarm symptoms, recommending the evaluation of full blood count, C-reactive protein, serology for coeliac disease, and faecal calprotectin, and consideration of diagnosing bile acid diarrhoea. Colonoscopy with random biopsies in both the right and left colon is recommended in patients older than 50 years and in presence of alarm features. Regarding treatment, a strong consensus was achieved for the use of a diet low fermentable oligo-, di-, monosaccharides and polyols, gut-directed psychological therapies, rifaximin, loperamide, and eluxadoline. A weak or conditional recommendation was achieved for antispasmodics, probiotics, tryciclic antidepressants, bile acid sequestrants, 5-hydroxytryptamine-3 antagonists (i.e. alosetron, ondansetron, or ramosetron). A multinational group of European experts summarized the current state of consensus on the definition, diagnosis, and management of IBS-D and FDr. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng |
653 | a abdominal pain | |
653 | a clinical practice guidelines | |
653 | a diarrhea | |
653 | a FDr | |
653 | a functional | |
653 | a bowel disorders | |
653 | a functional diarrhea | |
653 | a IBS-D | |
653 | a irritable bowel syndrome | |
653 | a bile-acid malabsorption | |
653 | a intestinal bacterial overgrowth | |
653 | a gluten-free | |
653 | a diet | |
653 | a double-blind | |
653 | a celiac-disease | |
653 | a fecal incontinence | |
653 | a gastrointestinal | |
653 | a disorders | |
653 | a lactose-malabsorption | |
653 | a rome iii | |
653 | a capsule endoscopy | |
653 | a Gastroenterology & Hepatology | |
700 | 1 | a Zingone, F.4 aut |
700 | 1 | a Barberio, B.4 aut |
700 | 1 | a Marasco, G.4 aut |
700 | 1 | a Akyuz, F.4 aut |
700 | 1 | a Akpinar, H.4 aut |
700 | 1 | a Barboi, O.4 aut |
700 | 1 | a Bodini, G.4 aut |
700 | 1 | a Bor, S.4 aut |
700 | 1 | a Chiarioni, G.4 aut |
700 | 1 | a Cristian, G.4 aut |
700 | 1 | a Corsetti, M.4 aut |
700 | 1 | a Di Sabatino, A.4 aut |
700 | 1 | a Dimitriu, A. M.4 aut |
700 | 1 | a Drug, V.4 aut |
700 | 1 | a Dumitrascu, D. L.4 aut |
700 | 1 | a Ford, A. C.4 aut |
700 | 1 | a Hauser, G.4 aut |
700 | 1 | a Nakov, R.4 aut |
700 | 1 | a Patel, N.4 aut |
700 | 1 | a Pohl, D.4 aut |
700 | 1 | a Sfarti, C.4 aut |
700 | 1 | a Serra, J.4 aut |
700 | 1 | a Simrén, Magnus,d 1966u Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine4 aut0 (Swepub:gu)xsimrm |
700 | 1 | a Suciu, A.4 aut |
700 | 1 | a Tack, J.4 aut |
700 | 1 | a Toruner, M.4 aut |
700 | 1 | a Walters, J.4 aut |
700 | 1 | a Cremon, C.4 aut |
700 | 1 | a Barbara, G.4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för medicin4 org |
773 | 0 | t United European Gastroenterology Journald : Wileyg 10:6, s. 556-584q 10:6<556-584x 2050-6406x 2050-6414 |
856 | 4 8 | u https://gup.ub.gu.se/publication/320178 |
856 | 4 8 | u https://doi.org/10.1002/ueg2.12259 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.